JP2013087119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013087119A5 JP2013087119A5 JP2012229438A JP2012229438A JP2013087119A5 JP 2013087119 A5 JP2013087119 A5 JP 2013087119A5 JP 2012229438 A JP2012229438 A JP 2012229438A JP 2012229438 A JP2012229438 A JP 2012229438A JP 2013087119 A5 JP2013087119 A5 JP 2013087119A5
- Authority
- JP
- Japan
- Prior art keywords
- uric acid
- high blood
- blood uric
- pharmaceutical composition
- acid levels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 10
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 10
- 229940116269 uric acid Drugs 0.000 claims 10
- 239000008280 blood Substances 0.000 claims 9
- 210000004369 blood Anatomy 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- -1 5-Amino-1H-pyrazol-4-yl Chemical group 0.000 claims 4
- 201000005569 Gout Diseases 0.000 claims 3
- 201000001431 Hyperuricemia Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims 2
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims 2
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 claims 2
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- ZYSCOUXLBXGGIM-UHFFFAOYSA-N 4-[2-(5-amino-1h-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-n-(1,3-thiazol-4-yl)benzenesulfonamide Chemical compound N1N=CC(C=2C(=CC=C(Cl)C=2)OC=2C(=CC(=C(F)C=2)S(=O)(=O)NC=2N=CSC=2)Cl)=C1N ZYSCOUXLBXGGIM-UHFFFAOYSA-N 0.000 claims 1
- 108010092464 Urate Oxidase Proteins 0.000 claims 1
- 229960003459 allopurinol Drugs 0.000 claims 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 claims 1
- 229960000590 celecoxib Drugs 0.000 claims 1
- 229960001338 colchicine Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960005101 febuxostat Drugs 0.000 claims 1
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 108010084837 rasburicase Proteins 0.000 claims 1
- 229960000424 rasburicase Drugs 0.000 claims 1
- 230000008060 renal absorption Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000003064 xanthine oxidase inhibitor Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549823P | 2011-10-21 | 2011-10-21 | |
| US61/549,823 | 2011-10-21 | ||
| US201261700582P | 2012-09-13 | 2012-09-13 | |
| US61/700,582 | 2012-09-13 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013069382A Division JP2013127010A (ja) | 2011-10-21 | 2013-03-28 | 新規な塩および医学的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013087119A JP2013087119A (ja) | 2013-05-13 |
| JP2013087119A5 true JP2013087119A5 (enExample) | 2013-06-20 |
| JP5363636B2 JP5363636B2 (ja) | 2013-12-11 |
Family
ID=47297336
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012229438A Expired - Fee Related JP5363636B2 (ja) | 2011-10-21 | 2012-10-17 | 新規な塩および医学的使用 |
| JP2013069382A Ceased JP2013127010A (ja) | 2011-10-21 | 2013-03-28 | 新規な塩および医学的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013069382A Ceased JP2013127010A (ja) | 2011-10-21 | 2013-03-28 | 新規な塩および医学的使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140248252A1 (enExample) |
| EP (1) | EP2768505A1 (enExample) |
| JP (2) | JP5363636B2 (enExample) |
| KR (1) | KR20140072099A (enExample) |
| CN (2) | CN103889420B (enExample) |
| AR (1) | AR093188A1 (enExample) |
| AU (2) | AU2012324405B2 (enExample) |
| BR (1) | BR112014009165A8 (enExample) |
| CA (1) | CA2852039A1 (enExample) |
| HK (1) | HK1220198A1 (enExample) |
| IL (1) | IL232174A0 (enExample) |
| MX (1) | MX2014004737A (enExample) |
| RU (1) | RU2609011C2 (enExample) |
| SG (1) | SG11201401238TA (enExample) |
| TW (2) | TW201514177A (enExample) |
| WO (1) | WO2013057722A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT376100B (de) | 1980-03-27 | 1984-10-10 | Menhardt Walther Dr | Selbstregelndes heizelement |
| EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
| TW201512171A (zh) * | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
| TW201443025A (zh) * | 2013-04-19 | 2014-11-16 | Pfizer Ltd | 化學化合物 |
| WO2016034971A1 (en) | 2014-09-04 | 2016-03-10 | Pfizer Limited | Sulfonamides derivatives as urat1 inhibitors |
| JP6860245B1 (ja) * | 2020-01-30 | 2021-04-14 | 株式会社ファーストスクリーニング | 健康状態判定支援装置、健康状態判定支援プログラム、および健康状態判定支援システム |
| CN120913662B (zh) * | 2025-10-10 | 2025-12-02 | 吉林农业大学 | 一种鸡粪粗蛋白含量检测模型构建方法、系统和检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3232922A1 (de) * | 1982-09-04 | 1984-03-08 | Hoechst Ag, 6230 Frankfurt | Sulfamoylbenzophenon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| ATE522513T1 (de) * | 2001-03-12 | 2011-09-15 | Ono Pharmaceutical Co | N-phenylarylsulfonamidverbindung, arzneimittel das diese verbindung als wirkstoff enthält, zwischenprodukt für die verbindung und verfahren zu dessen herstellung |
| JP5463285B2 (ja) * | 2007-07-13 | 2014-04-09 | アイカジェン， インコーポレイテッド | ナトリウムチャネル阻害物質 |
| HRP20150355T1 (hr) * | 2009-01-12 | 2015-06-19 | Pfizer Limited | Sulfonamidni derivati |
| WO2010135530A2 (en) * | 2009-05-20 | 2010-11-25 | Ardea Biosciences, Inc. | Compounds, compositions and methods for modulating uric acid levels |
| GB0922434D0 (en) * | 2009-12-22 | 2010-02-03 | Ucb Pharma Sa | antibodies and fragments thereof |
-
2012
- 2012-10-17 JP JP2012229438A patent/JP5363636B2/ja not_active Expired - Fee Related
- 2012-10-19 CA CA2852039A patent/CA2852039A1/en not_active Abandoned
- 2012-10-19 EP EP12797982.1A patent/EP2768505A1/en not_active Withdrawn
- 2012-10-19 KR KR1020147010078A patent/KR20140072099A/ko not_active Abandoned
- 2012-10-19 BR BR112014009165A patent/BR112014009165A8/pt active Search and Examination
- 2012-10-19 AR ARP120103935A patent/AR093188A1/es unknown
- 2012-10-19 RU RU2014115733A patent/RU2609011C2/ru not_active IP Right Cessation
- 2012-10-19 WO PCT/IB2012/055760 patent/WO2013057722A1/en not_active Ceased
- 2012-10-19 CN CN201280051625.XA patent/CN103889420B/zh not_active Expired - Fee Related
- 2012-10-19 MX MX2014004737A patent/MX2014004737A/es unknown
- 2012-10-19 AU AU2012324405A patent/AU2012324405B2/en not_active Ceased
- 2012-10-19 TW TW104101236A patent/TW201514177A/zh unknown
- 2012-10-19 US US14/351,649 patent/US20140248252A1/en not_active Abandoned
- 2012-10-19 TW TW101138808A patent/TWI473802B/zh not_active IP Right Cessation
- 2012-10-19 CN CN201510919689.2A patent/CN105418599A/zh active Pending
- 2012-10-19 SG SG11201401238TA patent/SG11201401238TA/en unknown
-
2013
- 2013-03-28 JP JP2013069382A patent/JP2013127010A/ja not_active Ceased
-
2014
- 2014-04-22 IL IL232174A patent/IL232174A0/en unknown
- 2014-10-07 HK HK16108332.2A patent/HK1220198A1/zh unknown
-
2016
- 2016-02-15 AU AU2016200946A patent/AU2016200946A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012184234A5 (enExample) | ||
| JP2013087119A5 (enExample) | ||
| JP2013528655A5 (enExample) | ||
| JP2014012726A5 (enExample) | ||
| JP2013531028A5 (enExample) | ||
| JP2015508749A5 (enExample) | ||
| JP2013528650A5 (enExample) | ||
| JP2015057436A5 (enExample) | ||
| BR112013032122A2 (pt) | liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos | |
| JP2017513836A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| HRP20151399T1 (hr) | Kinazni inhibitor koji regulira signalni put apoptoze | |
| JP2014532760A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| CY1123346T1 (el) | Παραγωγα 5-[2-(πυριδιν-2-υλαμινο)-1,3-θειαζολ-5-υλ]-2,3-διυδρο-1η-ισοϊνδολ-1-ονης και χρηση τους ως διπλοι αναστολεις της 3-κινασης φωσφατιδυλοϊνοσιτολης δελτα & γαμμα | |
| JP2013502446A5 (enExample) | ||
| PH12018500261A1 (en) | Azole benzene derivative | |
| MX390332B (es) | Una composición farmacéutica que comprende febuxostat e inosina para usarse en el tratamiento de enfermedades en donde existe una deficiencia de atp intracelular. | |
| JP2015510916A5 (enExample) | ||
| RU2014115733A (ru) | Новая соль и медицинское применение | |
| JP2013507442A5 (enExample) | ||
| JP2017508817A5 (enExample) | ||
| JP2014532758A5 (enExample) | ||
| JP2018039810A5 (enExample) | ||
| CY1124383T1 (el) | Προληψη ή αγωγη παθησης ουρικου οξεος ή ποδαγρας |